Literature DB >> 19882499

Evaluation of a standardized protocol for processing adrenal tumor samples: preparation for a European adrenal tumor bank.

I K Johnsen1, S Hahner, J-J Brière, A Ozimek, A P Gimenez-Roqueplo, C Hantel, P Adam, J Bertherat, F Beuschlein.   

Abstract

Storage and tissue handling of surgical tumor specimen have been recognized as critical steps that can potentially affect reproducibility and comparability of molecular endpoints between laboratories. In the preparation of adrenal tumor tissue banking, three different protocols that simulate warm ischemia upon tumor removal (protocol I), thawing and refreezing cycles (protocol II), as well as storage of vital tumor samples (protocol III) were applied. For the first two protocols, samples were subdivided and either snap frozen or treated with a RNA preserving agent (RPA) while in protocol III different storage media were compared. Following these procedures, recovery and integrity of DNA, RNA, and protein by means of pulsed field electrophoresis, long-range PCR, real-time PCR, immunoblot, and immunohistochemistry (protocol I and II) as well as cell viability and steroidogenic capacity (protocol III) were investigated. While DNA integrity was not influenced by different treatment modalities, expression levels of adrenal marker genes were more affected in samples after snap freezing in comparison to RPA pretreatment. Moreover, storage at room temperature before and after freezing could be demonstrated to decrease the relative amount of protein phosphorylation (ERK) and enzymatic activity (succinate cytochrome c reductase) while overall protein levels were not significantly affected. Similarly, morphological or immunohistochemical evaluation was comparable between groups. For primary cell cultures generated after storage of tumor samples similar rates of viability were observable while steroid output varied between the groups. Overall, on the basis of the presented endpoints standardized operational procedures can be defined for a proposed European adrenal tumor biobank. Georg Thieme Verlag KG Stuttgart * New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19882499     DOI: 10.1055/s-0029-1241858

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

Review 1.  Pragmatic issues in biomarker evaluation for targeted therapies in cancer.

Authors:  Armand de Gramont; Sarah Watson; Lee M Ellis; Jordi Rodón; Josep Tabernero; Aimery de Gramont; Stanley R Hamilton
Journal:  Nat Rev Clin Oncol       Date:  2014-11-25       Impact factor: 66.675

Review 2.  Biobanking in genomic medicine.

Authors:  Jane H Zhou; Aysegul A Sahin; Jeffrey N Myers
Journal:  Arch Pathol Lab Med       Date:  2015-06       Impact factor: 5.534

3.  Long-term storage of endocrine tissues at - 80°C does not adversely affect RNA quality or overall histomorphology.

Authors:  Adam Andreasson; Nimrod B Kiss; C Christofer Juhlin; Anders Höög
Journal:  Biopreserv Biobank       Date:  2013-12       Impact factor: 2.300

4.  Establishment and management of a lung cancer biobank in Eastern China.

Authors:  Keke Yu; Jie Zhang; Xin Li; Lei Xu; Ye Zhang; Jie Xing; Jinchen Shao; Lei Zhu; Jinguo Liu; Lanxiang Zhao; Baohui Han
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

5.  Impact of Cold Ischemic Time and Freeze-Thaw Cycles on RNA, DNA and Protein Quality in Colorectal Cancer Tissues Biobanking.

Authors:  Xin-Juan Fan; Yan Huang; Pei-Huang Wu; Xin-Ke Yin; Xi-Hu Yu; Xin-Hui Fu; Li-Li Feng; Yun-Long Wang; Hong-Jun Yi; Zhi-Ting Chen; Jun-Xiang Yin; Da-Lu Zhang; Wei-Xing Feng; Shao-Mei Bai; Taewan Kim; Gordon B Mills; Yi-Ling Lu; Xiang-Bo Wan; Lei Wang
Journal:  J Cancer       Date:  2019-08-27       Impact factor: 4.207

6.  Abiotic and past climatic conditions drive protein abundance variation among natural populations of the caddisfly Crunoecia irrorata.

Authors:  Joshua Niklas Ebner; Danilo Ritz; Stefanie von Fumetti
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.